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Abstract
Coronavirus disease 2019 (COVID-19) was reported at the end of 2019 in China for the first time and has rapidly spread
throughout the world as a pandemic. Since COVID-19 causes mild to severe acute respiratory syndrome, most studies in this
field have only focused on different aspects of pathogenesis in the respiratory system. However, evidence suggests that COVID-
19 may affect the central nervous system (CNS). Given the outbreak of COVID-19, it seems necessary to perform investigations
on the possible neurological complications in patients who suffered from COVID-19. Here, we reviewed the evidence of the
neuroinvasive potential of coronaviruses and discussed the possible pathogenic processes in CNS infection by COVID-19 to
provide a precise insight for future studies.
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Abbreviations
ACE2 Angiotensin-converting enzyme 2
ARDS Acute respiratory distress syndrome
BBB Blood-brain barrier
CNS Central nervous system
CoV Coronavirus
CoVs Coronaviruses
COVID-19 Coronavirus disease 2019
HCoVs Human coronaviruses
HCoV-OC43 Human coronavirus OC43
HCoV-229E Human coronavirus 229E
MERS Middle East respiratory syndrome
SARS Severe acute respiratory syndrome
Introduction
Coronaviruses (CoVs) belong to a large family of viruses that
cause diseases in mammals and birds (Liu et al. 2020). CoVs
are responsible for severe respiratory illness such as Middle
East respiratory syndrome (MERS) and severe acute respira-
tory syndrome (SARS) in humans. Six types of these viruses
affect human cases, such as 229E, NL63, OC43, HKU1,
MERS-CoV, and SARS-CoV (Matoba et al. 2015; Myint
1995). A novel CoV (SARS-CoV-2) also known as COVID-
19 has been reported in China in December 2019 for the first
time (Lam et al. 2020). Recently, the World Health
Organization (WHO) has declared that new coronavirus dis-
ease is a pandemic. The symptoms of COVID-19 are very
similar to MERS and SARS including shortness of breath,
breathing difficulties, cough, fatigue, sore throat, and fever.
Likewise, some symptoms such as headaches, nausea, confu-
sion, dizziness, and vomiting are reported (Jiang et al. 2020).
Studies have shown that MERS-CoV, SARS-CoV, and
COVID-19 may cause acute respiratory distress syndrome
(ARDS), hepatic, and intestinal diseases (Leung et al. 2003;
Peiris et al. 2003; Wu et al. 2020; Zhang et al. 2020). It has
been indicated that 229E-CoV, OC43-CoV, and SARS-CoV
lead to neurological complications in some patients and
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animal models (Bonavia et al. 1997; Desforges et al. 2014;
Jacomy et al. 2006; Jevšnik et al. 2016; Li et al. 2016b; St-
Jean et al. 2004) (Table 1). Since the structure and pathogen-
esis of most CoVs are similar (Butler et al. 2006; St-Jean et al.
2004; Yuan et al. 2017) and the behavior of COVID-19 is
unknown, attention to the other organs whichmay be involved
(e.g., central nervous system) and follow-up of patients for
neurological complication by designing perspective cohort
studies are essential. Therefore, the aim of the present study
was to review neuroinvasive potential and neurotropism ef-
fects of human coronaviruses (HCoVs) and discuss the prob-
able neurological complication followed by COVID-19 to
give an insight for future studies.
Search strategy and selection criteria
References for this review were classified through searches of
PubMed and Google Scholar for articles published from 1967
to April 15, 2020. We used the terms “coronavirus,” “SARS,”
“SARS-CoV-2,” “MERS,” “229E-CoV,” and “COVID-19,”
with combina t ion the te rms “nervous sys tem,”
“neuroinvasion,” and “neurological manifestation.” In vitro
studies on neurotropism potentials of CoVs on neural or glial
cells cultures were considered. Furthermore, in vivo investiga-
tions were included for injection routes (intranasal and intraper-
itoneally) of neuroinvasion. Finally, clinical finding searched
and included for neurological signs related to CoVs infections.
How can CoVs enter the CNS?
Data from clinical and animal studies have shown that CoVs
can cross the blood-brain barrier (BBB) and exert
neuroinvasive properties (Cabirac et al. 1994; Cavanagh
2005; Desforges et al. 2013; Li et al. 2016b; Niu et al. 2020;
Talbot et al. 2011; J. Xu et al. 2005). The precise mechanisms
of penetration into the CNS have not been fully understood.
However, four routes of transmission have been suggested.
First of all, olfactory nerves are an accessible route for the
invasion of CoVs into the CNS (Fig.1 (1)). Intranasal inocu-
lation of mice with MERS-CoV causes brain infection with
the involvement of thalamus and brain stem (Li et al. 2016a).
Furthermore, it has been reported that the rate of mortality in
mice was increased when infected with SARS-CoV through
intranasal inoculation. It might be due to neuroinvasion and
neural death in the brain stem (Netland et al. 2008). Cellular
invasion is the secondway to enter the CNS (Fig. 1 (2)). In this
way, infected monocytes/macrophages by CoVs cross the
BBB and exert neuroinvasive properties. MERS-CoV can in-
fect monocyte and T lymphocyte in human cell lines (Chan
et al. 2013). In vitro studies have reported that infected human
monocytes/macrophages can act as a viral reservoir and
spread viruses to other tissues (Collins 2002; Desforges et al.
2007). The third possible way which mediates neuroinvasion
of CoVs is microvascular endothelial cells of BBB structure
(Fig.1 (3)). These cells can express two types of SARS-CoV
receptors, such as angiotensin-converting enzyme 2 (ACE2)
and CD209L (J. Li et al. 2007). Therefore, SARS-CoVs can
enter the CNS through interaction with ACE2 and CD209L
receptors. The last transmitting way into the CNS is trans-
synaptic transmission through peripheral nerves (Figs.1 (4)).
Injection of hemagglutinating encephalomyelitis virus (HEV)
in hindfoot of rat leads to the emersion of the virus in the
motor cortex through coated vesicles in trans-synaptic route
(Li et al. 2013).
Human coronavirus family has neuroinvasion
potential
Evidence suggests that several types of infected human coro-
navirus have neuroinvasion potential. For example, the type of
human coronavirus 229E (HCoV-229E) causes neurological
manifestation through neuroinvasion. Several studies have
been indicated that human neural cell culture was infected
by HCoV-229E (Arbour et al. 1999; Bonavia et al. 1997;
Table 1 Neurological manifestations and pathological findings related to human coronaviruses family infections
Human
coronaviruses
Type of Study Clinical signs/pathological findings References
CoV-229E Postmortem analysis of brain samples Neuroinvasion in multiple sclerosis (Arbour et al. 2000)
CoV-OC43 Postmortem analysis of brain
samples or CSF sampling
Neuroinvasion in multiple sclerosis,
demyelination, and encephalomyelitis
(Arbour et al. 2000; Yeh et al. 2004)
SARS-CoV Clinical human study and
postmortem analysis
Generalized tonic-clonic seizure, CSF infection,
glial cells hyperplasia, neural cell necrosis,
neuroinflammation, brain edema
(Gu et al. 2005; Lau et al. 2004;
J. Xu et al. 2005)
MERS-CoV Clinical human studies Ataxia, confusion, dizziness, headache (Algahtani et al. 2016; Kim et al. 2017)
SARS-CoV-2 Clinical human studies Headaches, nausea, confusion, dizziness,
impaired consciousness, ataxia, acute
cerebrovascular diseases, vomiting, epilepsy,
and skeletal muscle symptoms
(Guan et al. 2020; Li et al. 2020;
Mao et al. 2020a; Mao et al. 2020b)
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Lachance et al. 1998). It has also been reported that HCoV-
229E can increase the production of pro-inflammatory
cytokines in monocytes (Desforges et al. 2007). Also, post-
mortem analysis of brain multiple sclerosis patients showed a
presence of HCoV (Arbour et al. 2000). Another human co-
ronavirus which is very similar to HCoV-229E known as
OC43 (HCoV-OC43) is responsible for the common cold
and lower respiratory tract infections such as pneumonia
(Vabret et al. 2003). It has been reported that neuronal cells
derived from mouse dorsal root ganglia and human astrocyte
cells produced HCoV-OC43 antigen and infectious virus
(Pearson and Mims 1985) (Bonavia et al. 1997). The produc-
tion of pro-inflammatory cytokines increased and induced
neural injuries when human astrocyte culture was infected
by HCoV-OC43 (Edwards et al. 2000). HCoV-OC43
(Jacomy et al. 2006; Stodola et al. 2018) caused neuropathy
and gliopathy by activating the apoptosis cascades in cell cul-
tures (Jacomy et al. 2006). Furthermore, neuroinflammation
following by neuroinvasion has been shown in mice when
HCoV-OC43 was inoculated intraperitoneally (Jacomy and
Talbot 2003). Encephalitis, neuronal degeneration, microglia
activation, and decreasing locomotor activity were also ob-
served following the administration of HCoV-OC43 in mice
(Jacomy et al. 2006). Identically, intranasal inoculation of vi-
rus leads to neuroinvasion (Butler et al. 2006; St-Jean et al.
2004). In a postmortem study, a higher prevalence of HCoV-
OC43 was seen in the brain multiple sclerosis patients
(Arbour et al. 2000). In a case report study, the test of
HCoV-OC43 was positive in a child with encephalomyelitis
(Yeh et al. 2004).
Another example of a neuroinvasive function is SARS-
CoV which is identified in southern China and caused more
than 900 deaths in the world until Jun 2003 (Chan-Yeung and
Xu 2003) (Vu et al. 2004). SARS-CoVs could penetrate into
the CNS and cause neuropathy and gliopathy (Guo et al.
2008). An increase of pro-inflammatory cytokines was ob-
served after intranasal inoculation of SARS-CoV in mice
brains. The presence of the virus in the brain tissue was con-
firmed by RT-PCR (McCray et al. 2007) (Netland et al. 2008).
Generalized tonic-clonic convulsion has been reported in a
patient who suffered from SARS disease. In this case, the
presence of SARS-CoV in cerebrospinal fluid was positive
(Lau et al. 2004). Also, glial cells hyperplasia and neural cell
necrosis in a cytokine manner mechanism were detected in the
brain sample from a patient with SARS (Xu et al. 2005). A
postmortem analysis has also been shown that SARS-CoV is
capable to infect the neural cells in the hypothalamus and
cortex and cause brain edema in patients with SARS disease
(Gu et al. 2005). Additionally, MERS-CoVas an HCoVs can
infect human neuronal cell line culture (Zaki et al. 2012)
(Chan et al. 2013). Also, a report study indicated that two
patients with MERS-CoV infection had severe neurological
Fig. 1 Transmission routes of coronaviruses into the CNS. (1) Intranasal
inoculation of coronaviruses can lead to neuroinvasion through primary
olfactory neurons in the olfactory epithelium and mitral/tufted cells in the
olfactory bulb. (2) Infectedmonocytes can cross fromBBB via diapedesis
and infect glial and neuronal cells. (3) Interaction between CoV and
ACE2 receptors on BBB endothelial cells can enter into the CNS. (4)
Finally, viruses can enter the CNS through peripheral nerves via trans-
synaptic transmission. ACE2, angiotensin-converting enzyme 2; CNS,
central nervous system; PNS, peripheral nervous system
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manifestations (Algahtani et al. 2016). In the same way, it has
been reported that some neurological implications, such as
weakness of limbs or hand and hyperreflexia in deep tendon
reflex were seen in patients with MERS-CoV infection (Kim
et al. 2017).
It is interesting to note that neurological signs, such as
headache (Chen et al. 2020; Huang et al. 2020; Wang et al.
2020; Woelfel et al. 2020; Xu et al. 2020; Yang et al. 2020),
confusion, dizziness, impaired consciousness, ataxia, epilep-
sy, and skeletal muscle symptoms in patients with COVID-19
were reported (Guan et al. 2020; Li et al. 2020; Liang et al.
2020; Mao et al. 2020a; Mao et al. 2020b). It might be due to
neuroinvasive property. However, few researchers have been
able to draw on any systematic research into this topic. But it
has been recently suggested that the interaction of SARS-
CoV-2 with ACE2 receptors on the neural cells can involve
in the pathophysiology of neuroinvasion and neural damages
following COVID-19 infection (Baig et al. 2020). Besides
that, an unpublished report from Beijing Ditan Hospital
showed that the encephalitis was observed in a patient with
COVID-19 (Huaxia 2020). Also, neuroimaging techniques
and EEG data in two new cases revealed hemorrhagic necro-
tizing encephalopathy (Poyiadji et al. 2020), epileptogenicity,
and encephalomalacia (Filatov et al. 2020) in relation to
SARS-CoV-2 infection. Furthermore, in two currently cases,
a 74-year-old man and a 58-year-old woman have been con-
firmed with neurological manifestations as a consequence of
the SARS-CoV-2 infection (Lanese 2020; Rahhal 2020). The
74-year-old patient had temporarily lost the ability to speak in
Florida (Rahhal 2020). The case of 58-year-old woman had
confusion, lethargy, and disorientation signs. The brain CT
scans and magnetic resonance imaging (MRI) revealed injury
in the thalamus, hemorrhage, and necrotizing encephalopathy
(Lanese 2020). In contrast to another type of HCoVs, there is
much less information about the effects of neuroinvasive and
neurotropism of COVID-19.
Conclusion remarks and future perspective
Taken together, data from the above-mentioned studies con-
firm the neuroinvasive properties of HCoVs and their effects
on CNS. Although the exact mechanism of neuroinvasion is
still unclear, some penetration routes, such as olfactory epithe-
lium, cellular infection, BBB structure, and trans-synaptic
transmission, have been suggested. Considerably, more work
will need to be done to determine the long-term effects of
COVID-19 on CNS. Therefore, we suggest that a well-
designed cohort study can provide powerful results for their
effects. In the same way, further experiments using in vitro,
in vivo, and postmortem studies could shed more light on the
possible neuroinvasion and neural injuries after SARS-CoV-2
infection.
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